Life sciences face ‘complex’ and ‘changed’ risk landscape, says WTW

Credit: Shutterstock/Barbol

Life science firms must address new risks driven by changes to their business during the response to Covid-19, with insurers “playing catchup”, according to a sector report from Willis Towers Watson (WTW). WTW says the life science sector is still running with elevated supply chain risks as a result of the pandemic, adding that sudden progress in technical innovations and…

Please register or login to view the full post